Eric Bushlow, Cardiovascular Roundtable
Medication management remains challenging for providers as patients continue to be readmitted for non-compliance with medication. With readmission penalties looming and the gradual shift to value-based models of care, programs must rethink how they can help modify patient behavior outside the hospital setting.
New technologies offer some promise in resolving adherence issues, leveraging reminders and behavioral modification to boost compliance. However many of these solutions have seen limited provider adoption aiming to address the growing readmissions problem.
Read more »
The FDA last week released a number of updates on the use of statins, in particular highlighting contraindicated medications and potential side effects. Studies have linked statins to increases in glycosylated hemoglobin (HbA1c), adverse effects on liver function, and potential cognitive impairment. While the FDA did not place emphasis on cognitive impairment, they did acknowledge the effects of statins on increased blood sugar and the rare occurrence of reduced liver functionality.
Read more »